Merck to Acquire Verona Pharma in $10 Billion Deal, Adding Ohtuvayre® to Strengthen Respiratory Portfolio and Expand Long-Term Growth in COPD Market Merck & Co., known as MSD outside the U.S. and Canada, today announced a definitive agreement to acquire…
Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology (2020–2025): An In-Depth Analysis of Industry Trends, Financials, and Strategic Partnerships new industry report titled “Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2020–2025.” This updated resource offers a detailed examination of…
WHO Applauds IMF’s Landmark $700 Million Support to Jordan for Pandemic Preparedness and Response The World Health Organization (WHO) has lauded a groundbreaking decision by the International Monetary Fund (IMF) Executive Board to approve the first-ever Resilience and Sustainability Facility…
ISS Backs Glass Lewis in Supporting SINOVAC’s Current Board, Rejects Former Slate Ahead of Special Meeting SINOVAC Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that Institutional Shareholder Services Inc. (ISS), one of the most…
CroíValve Awarded €12.5M in Horizon Europe EIC Accelerator Funding to Advance Novel Treatment for Tricuspid Regurgitation CroíValve, a Dublin-based medical device company committed to transforming the treatment of tricuspid regurgitation (TR), has secured a major funding boost through the European…
Comprehensive Report Reveals Key Trends in Gynecology Collaboration and Licensing Deals from 2016 to 2025 Gynecology Collaboration and Licensing Deals report offers a deep dive into the evolving landscape of partnerships in women’s health, providing unparalleled insights into over 150…
Sunshine Biopharma Launches NIOPEG® Biosimilar in Canada, Targeting $10B Biologics Market Sunshine Biopharma Inc. (NASDAQ: SBFM), a pharmaceutical company focused on developing and commercializing life-saving medicines across oncology, antiviral therapies, and other therapeutic areas, has announced the commercial launch of…
Abeona Therapeutics Secures $155 Million from Sale of Priority Review Voucher, Strengthening Financial Position Ahead of ZEVASKYN Launch Abeona Therapeutics Inc. (Nasdaq: ABEO), a clinical-stage biopharmaceutical company focused on developing gene and cell therapies for rare genetic diseases, has officially…
Gilead Targets HIV Prevention Dominance With Twice-Yearly Yeztugo as GSK Mounts a Defense Gilead Sciences is taking a bold step to further entrench itself as the dominant force in HIV care, this time with its latest innovation in pre-exposure prophylaxis…
Merck Finalizes $3.4 Billion Acquisition of SpringWorks Therapeutics to Strengthen Rare Tumor Portfolio and Drive Sustainable Healthcare Growth Merck, a global leader in science and technology, today announced the successful completion of its acquisition of SpringWorks Therapeutics, Inc. for an…
CVS Health Launches Workforce Innovation and Talent Center in Chicago to Strengthen Community Employment and Training Opportunities In a significant step toward fostering economic opportunity and addressing workforce gaps, CVS Health has officially launched its newest Workforce Innovation and Talent…
Royalty Pharma and Revolution Medicines Forge $2 Billion Strategic Funding Pact to Accelerate Global Development of RAS Cancer Therapies Royalty Pharma plc, a prominent funder of innovation in the biopharmaceutical industry, announced a transformative agreement with Revolution Medicines, Inc., securing…
